Respiratory Distress Syndrome in Preterm Infants
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome in Preterm Infants.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation. [Phase 3]
Phase 3 trial evaluating the respiratory effects of the LISA method with Propofol sedation versus no sedation in preterm infants with respir…
-
FDA approval · 2009-02-10FDA Approved: SURVANTA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for SURVANTA (beractant) by AbbVie, authorizing changes to its labeling and/or indications.